H5N1 Moratorium Extended

The head of a US infectious disease funding body urges researchers to continue the voluntary cessation of research on avian influenza.

Written byEdyta Zielinska
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases (NIAID), this week (July 31) called for researchers to continue a moratorium on avian influenza research, until researchers could win the opinion of the public.

"You will unquestionably lose the battle for public support for your research if you ignore this issue," Fauci said at the annual meeting of the NIAID’s influenza research centers of excellence, according to ScienceInsider.

Some researchers have argued that there are sufficient regulations in place to secure and monitor potentially dangerous agents like genetically altered H5N1 virus. (Read more on what scientists are saying about avian influenza research in our April feature “Deliberating Over Danger.”) But the major concern, said Fauci, is not about researchers in the United States, but rather unregulated laboratories that might accidentally release an altered virus into the public. Fauci said that the influenza research community should try ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies